by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Email this page to a friend
Search this issue
Index - jump to page or section
Archive - view past issues
Australian Journal of Pharmacy : April 2005
product news ethical products cyproterone tablets, lactulose liquid and lamotrigine tablets. Called Cyprohexal, Lactocur and Lamitrin respectively, the new form- ulations are listed for pharmaceutical benefits from 1 April. Cyprohexal (cyproterone 50mg and 100mg tablets) are PBS-listed as Authority Items for treatment of hormonal disorders such as moderate to severe androgenisation in non-pregnant women. Three new Hexal generics H EXAL has launched three less- expensive formulations of Lactocur (lactulose liquid) is PBS-listed as a Restricted Benefit. Lactocur is an osmotically acting laxative, used mainly by the elderly and or chronically-ill patients where constipation is a complication of their disease. Lamitrin (lamotrigine 5mg, 25mg, 50mg, 100mg and 200mg dispersible and chewable tablets) is a second-line treatment for epileptic seizures not satisfactorily controlled by other anti-epileptic medications. Lamitrin is marketed by Hexal under a license agreement with GlaxoSmithKline Australia. s PBS for patients with normal ALT (alanine aminotransferase) who meet the Section 100 treatment eligibility criteria from 1 April 2005. The first and only published pegylated Combination therapy eradicates Hep-C P EGASYS RBV (peginterferon alfa 2a and ribavirin) will be available on the interferon studied in patients with normal ALT, Pegasys RBV combination therapy has been shown to produce sustained virological response (SVR) rates in more than 50 per cent of a patient population who were previously assumed not to need treatment. People with Hepatitis C and normal ALT levels have long been considered as ‘healthy’ carriers and, therefore, have commonly been denied treatment. It has over the counter Prevention better than cure S PORTS Medicine Australia has launched a national education program, Elastoplast Strap Smart, to assist active Australians in preventing sports-related injuries. In 2005, Sports Medicine Australia will introduce a series of Elastoplast Strap Smart clinics throughout Australia to teach sporting participants 258 ? THE AUSTRALIAN JOURNAL OF PHARMACY VOL 86 APRIL 2005 the correct and best strapping techniques to minimise injuries. The Elastoplast Strap Smart clinics will incorporate several injury prevention techniques and principles suitable for any age or fitness level including warm-up/cool-down, stretching and taping vulnerable joints and managing injuries. s been launched, to encourage patients aged 65 years or over to visit their GP to receive the polysaccharide pneumococcal vaccine (PPV), Pneumovax 23, now available free to these patients. The Commonwealth A become apparent however, that having normal ALT levels is not a true indicator that the liver is undamaged. To the contrary, studies have shown that almost 30 per cent of patients with normal ALT have liver fibrosis scores greater than two, indicating moderate liver damage requiring possible treatment. Government is funding the vaccine with the aim to significantly decrease the hospitalisation and death caused by pneumococcal disease. The evidence from a Victorian s Government initiative shows that providing free pneumococcal vaccine can make a significant difference. The Victorian State Government funded pneumococcal vaccination for people aged 65 years or over from 1998 to 2004, resulting in a dramatic increase in vaccination coverage rates from 7 per cent in 1997 to 51 per cent in 2000, and a 36 per cent reduction in reported rates of invasive pneumococcal disease within four years. s patch which uses the ‘delivery optimised thermodynamics’ (DOT) matrix system, is now available on the PBS. The patch has a thin, soft and flexible design, and is smaller than a postage stamp. Applied twice weekly, it delivers bioidentical, plant-derived 17B-oes- tradiol, the same physiological oestrogen produced by a woman’s body. It delivers much lower doses of oestradiol directly into the bloodstream, bypassing the liver. Mini-me HRT E s Pneumo campaign under way widespread consumer awareness campaign has STRADOT (17B-oestradiol), a tiny, advanced oestrogen replacement